FDA Clearance Tracker · P150038-S008
ExAblate (Model 4000) System
Last checked: Nov 20, 2026Latest source record: Oct 24, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Oct 24, 2018
Approved
Time to decision
93 days
Received Jul 23, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P150038-S008
- Device name
- ExAblate (Model 4000) System
- Applicant
- Insightec
- Applicant location
- Tirat Carmel
- Received
- Jul 23, 2018
- Decided
- Oct 24, 2018
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P150038
Device type
- Device type
- MR-guided focused ultrasound system (POH)
- Device class
- Class III
- Specialty
- Neurology & Neurosurgery
FDA's approval statement
As written in FDA's record.
Approval to include the 2-year and 3-year post-market study outcomes in the device labeling.
Source documents
Other decisions for Insightec
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Exablate Model 4000 Type-1 SystemPMA supplement
P150038-S037 · Decided Jul 3, 2025 · 352 days after receipt · Panel Track
Device type: MR-guided focused ultrasound system (POH) · Neurology & Neurosurgery
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.